Sun Pharma To Launch Generic Semaglutide For Type 2 Diabetes In South Africa
Sun Pharmaceutical Industries Limited on Wednesday announced that it has received approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of semaglutide injection in South Africa for the treatment of adults with inadequately controlled type 2 diabetes mellitus as an adjunct to diet and exercise. Sun Pharma … Read more